| HOME >> BIOLOGY >> TECHNOLOGY |
"Interventional cardiology has continuously improved outcomes for the past 30 years," continued Burnett. "However there are still a significant number of events that take place in patients that have been treated in the cath lab, and many more victims of sudden heart attacks that don't make it to the cath lab at all. In both cases, the causes often remain unclear and unexplained by angiography. Volcano is committed to providing therapy guidance tools designed to augment angiography and provide physicians with the tools they need to continue advancing the specialty forward."
Live Case Demonstrations and Hands-On Demonstrations
During the week of TCT, Volcano will collaborate with physicians globally to provide a full schedule of live demonstration cases with Volcano's innovative intravascular imaging and intracoronary physiology products. These products are readily available to the interventional community as Volcano has more than 4,400 systems installed worldwide. Volcano will also host education, training and live demonstrations of the company's newest intravascular imaging and intracoronary physiology products at the Volcano booth #411.
About Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural
'/>"/>
| SOURCE Volcano Corporation Copyright©2009 PR Newswire. All rights reserved |